A Retrospective, Naturalistic Review Comparing Clinical Outcomes of In-Hospital Treatment with Risperidone and Olanzapine

By Snaterse M.  

Clinical Drug Investigation, Vol. 20, Iss. 3, 2000-09 ,pp. : 159-164

Adis International

Access to resources Recommend Favorite

Association of Co-Morbidities with Prescribing Patterns and Cost Savings: Olanzapine versus Risperidone for Schizophrenia

By Yu Wei   Ren Xinhua S.   Lee Austin F.   Herz Lawrence   Huang Yu-Hui   Kazis Lewis E.  

PharmacoEconomics, Vol. 24, Iss. 12, 2006-01 ,pp. : 1233-1248

Adis International

Access to resources Recommend Favorite

Olanzapine versus Risperidone in the Treatment of Schizophrenia: A Comparison of Costs among Texas Medicaid Recipients

By Rascati K.L.  

PharmacoEconomics, Vol. 21, Iss. 10, 2003-01 ,pp. : 683-697

Adis International

Access to resources Recommend Favorite

Cost Analysis of the Treatment of Schizophrenia in the UK: A Simulation Model Comparing Olanzapine, Risperidone and Haloperidol

By Almond S.  

PharmacoEconomics, Vol. 17, Iss. 4, 2000-04 ,pp. : 383-389

Adis International

Access to resources Recommend Favorite

Olanzapine versus Risperidone: A Prospective Comparison of Clinical and Economic Outcomes in Schizophrenia

By Edgell E.T.  

PharmacoEconomics, Vol. 18, Iss. 6, 2000-12 ,pp. : 567-579

Adis International

Access to resources Recommend Favorite